1043309

GlaxoSmithKline, LLC. — FEI 3004055938

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
January 26, 2018
Fiscal Year
2018
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Conshohocken, PA (United States)